Cytokine gene polymorphisms in children successfully withdrawn from immunosuppression after liver transplantation.

BACKGROUND Cytokine genetic polymorphisms have been associated with transplant outcome in some experimental and clinical studies, but the cytokine profile of patients who are clinically tolerant has not been investigated. AIM Allelic variations in tumor necrosis factor (TNF)-alpha, interferon (INF)-gamma, transforming growth factor (TGF)-beta1, interleukin (IL)-6, and IL-10 were evaluated in patients successfully withdrawn from immunosuppression. METHODS Pediatric liver transplant recipients who were successfully withdrawn from immunosuppression (n=12) or who are on minimal immunosuppression (n=7) were genotyped. A control group of liver recipients who required maintenance immunosuppression served as a control group (n=37). RESULTS Compared to the control group, low TNF- alpha and high/intermediate IL-10 profiles were seen in all 12 children maintained off immunosuppression and in 6 of 7 children requiring minimal immunosuppression. CONCLUSION Children successfully maintained off immunosuppression are more likely to have a genetic predisposition toward low TNF-alpha and high/intermediate IL-10 production. Children maintained on minimal immunosuppression exhibit a similar cytokine profile to those successfully weaned.

[1]  A. Donnenberg,et al.  Monitoring the patient off immunosuppression. Conceptual framework for a proposed tolerance assay study in liver transplant recipients. , 2001, Transplantation.

[2]  O. Salvatierra.  IN MEMORIUM: Felix T. Rapaport, MD September 27, 1929 to April 12, 2001 , 2001 .

[3]  B. Griffith,et al.  The effect of cytokine gene polymorphisms on pediatric heart allograft outcome. , 2001, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[4]  D. Purdie,et al.  Role of cytokine gene polymorphisms in acute rejection and renal impairment after liver transplantation , 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[5]  P. Hayes,et al.  Pretransplantation tumor necrosis factor‐α production predicts acute rejection after liver transplantation , 2000, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[6]  P. Hayes,et al.  The effect of polymorphisms in tumor necrosis factor-alpha, interleukin-10, and transforming growth factor-beta1 genes in acute hepatic allograft rejection. , 2000, Transplantation.

[7]  I. Hutchinson,et al.  Cytokine gene polymorphism and heart transplant rejection. , 1997, Transplantation.

[8]  T. Starzl,et al.  Weaning of immunosuppression in liver transplant recipients. , 1997, Transplantation.

[9]  S. Todo,et al.  Frequent achievement of a drug-free state after orthotopic liver transplantation. , 1993, Transplantation proceedings.

[10]  K. Olthoff,et al.  The role of tumor necrosis factor in allograft rejection. III. Evidence that anti-TNF antibody therapy prolongs allograft survival in rats with acute rejection. , 1991, Transplantation.

[11]  D. Chia,et al.  The role of tumor necrosis factor in allograft rejection. I. Evidence that elevated levels of tumor necrosis factor-alpha predict rejection following orthotopic liver transplantation. , 1990, Transplantation.